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Abstract  Magnesium and magnesium based alloys are lightweight metallic materials that are extremely biocompatib le 
and have similar mechanical properties to natural bone. These materials have the potential to function as an osteoconductive 
and biodegradable substitute in load bearing applicat ions in the field of hard t issue engineering. However, the effects of 
corrosion and degradation in the physiological environment of the body has prevented their wide spread applicat ion to date. 
The aim of this review is to examine the properties, chemical stability, degradation in situ and methods of improving the 
corrosion resistance of magnesium and its alloys for potential application in the orthopaedic field. To be an effective implant, 
the surface and sub-surface properties of the material needs to be carefully selected so that the degradation kinetics of the 
implant can be efficiently controlled. Several surface modification techniques are presented and their effectiveness in 
reducing the corrosion rate and methods of controlling the degradation period are discussed. Ideally, balancing the gradual 
loss of material and mechanical strength during degradation, with the increasing strength and stability of the newly forming 
bone tissue is the ultimate goal. If this goal can be achieved, then orthopaedic implants manufactured from magnesium based 
alloys have the potential to deliver successful clinical outcomes without the need for revision surgery.  
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1. Introduction 
The skeletal system of the human body is a complex 
three-dimensional structure that is important for two main 
reasons. The first arises from the need to structurally support 
the many body organs and other related tissues. The second 
is the attachment of the numerous muscle groups that are 
needed for body movement and locomotion. The skeleton is 
constructed of two types of tissue, the first is a hard t issue 
called bone and the second is a softer tissue composed of 
cartilag inous materials. The adult  human skeleton consists of 
206 bones[1]; some provide protection to the internal organs, 
while others perform specialized functions such as 
transmitting sound vibrations in the inner ear. The bone 
matrix also provides a natural reservoir for cells and mineral 
ions that play an important role in maintain ing the 
biochemical balance within the body. For example, calcium 
is an important element involved in muscular action and 
nerve conduction and its level in  the body is closely 
monitored and regulated by a process called homeostasis[2]. 
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Bone is a natural two phase organic-inorganic ceramic 
composite consisting of collagen fibrils with an embedded 
inorganic nano-crystalline component. The primary organic 
phase of the bone matrix is Type I collagen, which is secreted 
by osteoblast cells to form self-assembled fibrils[3, 4]. The 
fibrils are bundled together and orientate themselves parallel 
to the load-bearing axis of the bone. The fibrils are typically 
300 nm long, develop a 67 nm periodic pattern in which a 40 
nm gap or hole is formed between the ends of the fibrils and 
the remain ing 27 nm overlaps the bundle behind[5]. This 
pattern creates discrete and discontinuous sites for the 
deposition of plate-like nanometre sized hydroxyapatite 
(HAP) crystals, which forms the second phase of the bone 
matrix. HAP is a mineral predominantly composed of 
calcium phosphate which has the general chemical formula 
of[Ca10 (OH) 2(PO4)6]. It is the main inorganic component of 
bone and teeth, accounting for up to 65% by weight of 
cortical bone and in the case of teeth it accounts for 97 % by 
weight of dental enamel in mammalian  hard tissue[6]. The 
discontinuous discrete sites limit the growth of the HAP 
crystals and force the crystals to grow with a specific 
crystalline orientation which is parallel to the load-bearing 
axis of the bone and collagen fibrils. The crystal p lates 
typically have a length of 50 nm, a width of around 25 nm 
and on average a thickness of 3 nm[7-10]. The HAP also has 
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trace amounts of potassium, manganese, sodium, ch loride, 
hydrogen phosphate, citrate and carbonate[11]. The final 
component of the bone matrix consists of the non-collagen 
organic proteins such as the phosphor-protein group which 
are believed to regulate the formation  of the inorganic crystal 
phase by influencing the size, orientation and the 
depositional environment within the spaces between the 
collagen fibrils. The phosphor-protein group is also believed 
to be the source of calcium and phosphate ions used in the 
formation of the mineral phase[12]. 
The organic phase gives bone its flexib ility, while the 
inorganic phase provides bone with its structural rig idity[13, 
14]. The incorporation of organic and inorganic phases in the 
matrix g ives bone its unique mechanical properties such as 
toughness, strength, and stiffness. It is the combination of 
these properties that give bone and the skeletal system in 
general, its remarkable ability to withstand the various 
mechanical and structural loads encountered during normal 
and intense physical activity[15]. However, not all bone 
tissue in the body has the same properties and this is 
characterized by the presence of two types of bone. The first 
type consists of a hard outer layer of compact (cortical) t issue, 
while the second type forms the less dense and spongy 
(trabecular) tissue which fills the interior of the bone. This 
spongy interior contains marrow and the many blood vessels 
that supply nutrients and remove waste products from the 
bone tissues. Both the cortical bone and the trabecular bone 
are composed of the same organic and inorganic phases 
discussed above, but they differ in the amount of each phase 
present. The two bone types also differ in their respective 
porosities and in their structural arrangement. The amount of 
cortical and trabecular tissue found in bone is dependent on 
the external load being applied and the frequency of the 
load[16]. Despite its remarkable mechanical and structural 
properties bone can fracture from three main causes: 1) a 
fracture caused by sudden injury; 2) Fatigue or stress 
fractures resulting from repeated cyclic loads; and 3) 
Pathological fractures resulting from bone infections and 
tumours[17]. The surgical implantation of artificial 
biomaterials of specific size and shape is an effective 
solution in restoring the load bearing capacity and 
functionality of damaged bone tissue. The design and 
selection of biomaterials is highly  dependent on the specific 
medical applicat ion. Therefore, it  is imperative that new 
biomaterials being developed for load bearing orthopaedic 
implant applications should have excellent biocompatibility, 
comparable strength to natural bone, and produce no 
cytotoxicity effects[18, 19]. 
Metallic b iomaterials have been used since the early 1900s 
to replace damaged or diseased hard tissues. And as early as 
1907, a magnesium alloy was used by Lambotte, to secure a 
bone fracture in  the lower leg[20, 21]. Metallic  implants are 
generally used in  load bearing applications where their high 
mechanical strength and fracture toughness make’s them 
superior to ceramics, polymeric materials and polymer / 
ceramic composites. Metallic implant materials currently 
used include stainless steel, cobalt-chrome alloys and 
titanium and its alloys. At present there are two major 
problems associated with using the metallic implants. The 
first involves the mis match between the mechanical 
properties of the metallic alloy and the surrounding natural 
bone tissue. The elastic modulus of both stainless steel and 
cobalt-chrome alloys is around ten times greater than that of 
bone, while a titanium alloy such as Ti-6Al-4V is around five 
times greater[22]. Bone tissue is constantly undergoing 
remodelling and modification in response to imposed 
stresses produced by normal everyday activities. The 
mechanical mis match between bone and different metallic 
implant materials results in a clin ical phenomenon known as 
stress shielding. The stress-shielding phenomenon occurs 
when the implant carries the bulk of the load and the 
surrounding bone tissue experiences a reduced loading stress. 
The reduced loading stress experience by the surrounding 
bone tissue ultimately leads to bone resorption[23, 24]. The 
second problem stems from mechanical wear and corrosion 
of the implant and results in the release of toxic metallic ions 
such as chromium, cobalt and nickel into the body. These 
harmful metallic ions solicit an inflammatory response from 
the body’s immune system and the surrounding tissues 
which reduces the biocompatibility of the implant[25, 26, 
and 27]. This is in total contrast to the corrosion products of 
magnesium (Mg) which can be considered physiologically 
beneficial, with the adult body storing around 30 g of Mg in 
both muscle and bone tissue[28]. The importance of Mg to 
the body stems from the fact it is bivalent ion which is used 
to form apatite in the bone matrix and is also used in a 
number of metabolic processes within the body[29]. And 
recently, Robinson et al. reported the novel antibacterial 
properties of Mg metal against Escherichia coli, 
Pseudomonas aeruginosa and Staphylococcus aureus[30]. 
Mg is a lightweight, silvery-white metal that is relatively  
weak in its pure state and is generally used as an alloy in 
engineering applications. The density of Mg and its alloys 
are around 1.74 g/cm3 at 20oC, which is 1.6 and 4.5 times less 
dense than alumin ium and steel, respectively[31]. 
Interestingly, the density of Mg is slightly less than natural 
bone which ranges from 1.8 to 2.1 g/cm3, while the elastic 
modulus of pure Mg is 45 GPa and human bone varies 
between 40 and 57 GPa[32, 33 and 34]. Because of this close 
similarity in the respective elastic moduli, using Mg in  hard 
tissue engineering applications would greatly reduce the 
possibility of stress shielding and prevent bone resorption. 
Thus, Mg with its similar mechanical properties to natural 
bone, combined with its biocompatibility, makes it a 
promising material for the development of biodegradable 
orthopaedic implants[33, 35]. 
Polymeric materials have also been used in a number of 
tissue engineering applications since they have many 
attractive properties such as being lightweight, ductile in 
nature, biocompatible and biodegradable. Polymers are 
materials with large molecules composed of small repeating 
structural units called monomers. The monomers are usually 
attached by covalent chemical bonds, with cross-linking 
taking place along the length of the molecule. It is the 
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amount of cross-linking that gives the polymer its 
physiochemical propert ies. Many polymeric materials have 
been investigated since the body’s natural processes can 
easily handle the by-products resulting from their 
degradation, with the by-products being easily excreted in 
the urine. Natural polymers such as polysaccharides[36-40], 
chitosan[41-46], hyaluronic based derivatives[47-50] and 
protein based materials such as fibrin gel[51, 52] and 
collagen[53-56], have all produced favourable outcomes in a 
number of tissue engineering applications. 
Similar studies using synthetic biopolymers composed of 
simple high purity constituent monomers, fabricated under 
controllable formation conditions have produced a variety of 
tissue scaffolds and implants with tuneable and predictable 
physio-mechanical properties. These biopolymers also have 
low toxicity reactions with the body and their degradation 
rate can be easily controlled. Examples of synthetic 
biodegradable polymers include Poly (lact ic acid), 
PLA[57-62], Po ly (L-lactic acid), PLLA [63-66], Po ly 
(lactic-co-glycolic acid), PLGA[67-70], Poly-capro lactone 
PCL[71-74] and Poly  (g lycolic acid ), PGA [75-78]. These 
biopolymers are generally poly-α-hydrox esters that 
de-esterifies in the body as the polymer degrades to simple 
metabolites[79]. Currently  available b iodegradable sutures 
in clinical use are made from PLA and PGA. These synthetic 
biopolymers can also be made into different shapes and 
structures, such as pellets, rods, disks, films, and fibres as 
required for the specific applicat ion. Some of these 
applications include biodegradable sutures, bone and dental 
cements, bone grafting materials, plates, screws, pins, 
fixation devices and low load bearing applications in 
orthopaedics[80, 81]. However, even with their many 
attractive properties, biopolymers have low mechanical 
strength when compared to ceramics and metals, which has 
resulted in them being used in soft tissue reconstruction and 
low-load bearing applications. The major advantage that Mg 
and its alloys have over biopolymers is its superior 
mechanical strength, which is typically double that of 
biopolymers. 
Ceramics are non-metallic, inorganic materials that are 
used in hard tissue engineering applications where they are 
collectively termed bioceramics. The important properties of 
bioceramics that make them highly desirable fo r b iomedical 
applications are: 1) they are physically strong; 2) they are 
both chemically  and thermally stable; 3) they exh ibit  good 
wear resistance, and 4) they are durable in the body 
environment[82]. In addit ion, they are readily available, can 
be shaped to suit the application, they are biocompatible, 
hemocompatible, nontoxic, non-immunogenic and can be 
easily sterilised[83]. But unlike Mg and its alloys, 
bioceramics such as HAP, tend to be brittle, have low 
fracture toughness and are not as resilient. However, some 
bioceramics have found application in hip jo ints, coatings on 
implants, maxillofacial reconstruction, bone tissue 
engineering and drug delivery devices[81, 84-86]. 
A composite material consists of two or more distinct 
parts or phases[85]. The major advantage of using a 
composite biomaterial stems from the fact a single-phase 
material may not have all the required properties for a 
particular applicat ion[86]. However, by combin ing one or 
more phases with differing physical and chemical properties 
it is possible to create a composite material with superior 
properties to those of the indiv idual components. A good 
example of a natural composite is bone, which is a composed 
of Type 1 collagen and HAP. A typical manmade example of 
a biomedical composite is a b ioactive coating of HAP or a 
bioactive glass deposited on to the surface of a titanium 
implant to promote bone attachment[87]. Composites, such 
as a 2-phase HAP-polymer mixture have also been 
developed to create a biomaterial with similar p roperties to 
natural bone for hard tissue engineering applications[88]. 
Unfortunately, as mentioned above, biopolymers biodegrade 
with time and as a result, the load bearing capacity and 
fracture toughness of the implant will decline with time. 
When comparing the propert ies of Mg and its alloys with 
metals, polymers, ceramics and composites it can be shown 
that Mg and its alloys have many properties that are 
comparable, if not superior, see Table 1. However, despite its 
many advantages, Mg has the disadvantage of having a high 
corrosion rate in the body. And as a result, medical 
application of Mg based implants has been severely limited 
due to the electrolytic aqueous environment of the chloride 
rich body fluid (pH ranges between 7.4 and 7.6). 
Furthermore, there are two serious consequences of the rapid 
corrosion rate of Mg implants. The first is the rap id evolution 
of subcutaneous hydrogen gas bubbles which  are produced at 
a rate too high fo r the surrounding tissues to handle[89, 90]. 
These bubbles usually appear within the first week after 
surgery and can be easily  treated by drawing off the gas 
using a subcutaneous needle[91]. The second consequence 
of the high  corrosion rate is the loss of mechanical integrity 
of the Mg implant being used in the load bearing application. 
The rapid decrease in mechanical properties resulting from 
exposure to the body fluid environment means that the 
implant is unable to provide the necessary support for the 
healing bone tissue. Generally, the implant would be 
expected to maintain its mechanical integrity between 12 to 
18 weeks while the healing process takes place and then 
slowly degrade while natural bone tissues replace the 
implant[92]. 
This article reviews the biological performance, 
mechanical properties and potential applicat ion of 
biodegradable Mg based alloys for orthopaedic implants. 
The major disadvantage of using Mg in many engineering 
applications is its low corrosion resistance, especially in 
electrolytic, aqueous environments where it rapidly degrades. 
To slow the degradation rate in situ, factors influencing the 
corrosion rate such as alloying elements, surface 
modification and surface treatments are examined and 
discussed in the following sections. 
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2. Biological Corrosion of Magnesium 
2.1. Corrosion Mechanism 
When unprotected chemically pure magnesium is exposed 
to humid atmospheric air it develops a thick dull gray 
amorphous layer composed of magnesium hydroxide[Mg 
(OH)2]. The oxidation rate of this protective oxide layer is 
typically around 0.01 mm/yr, while the oxidation rate in salt 
water is around 0.30 mm/yr[93]. In magnesium alloys, 
controlling the alloying chemistry and the overall 
microstructure of the alloy can  significantly reduce the 
corrosion rate. 




In vitro corrosion rate 








(99.95%) 0.011 0.038 - 
AZ31 0.0065 - 1.17 
AZ91 0.0028 - 1.38 
LAE442 - - 0.39 
WE43 - 0.085 1.56 
Note: Table compiled from references[92, 96, 126, 213, 214 and 215] 
For orthopaedic applications pure magnesium finds the 
human body a highly  aggressive corrosive environment, see 
Table 2. The body flu ids are composed of water, dissolved 
oxygen, proteins and electro lytic ions such as chloride and 
hydroxide. In this environment, magnesium with a negative 
electrochemical potential o f -2.37 V, is very susceptible to 
corrosion and results in free ions migrat ing from the metal 
surface into the surrounding fluid environment. 
These ions can form chemical species, such as metal 
oxides, hydroxides, chlorides and other compounds. In 
thermodynamic terms, with the assumption that there is no 
barrier to oxidation of the metal surface, the reaction would 
be very rap id, evolv ing hydrogen gas and consuming the 
metal substrate surface. But in  reality the electrochemical 
reaction results in the migration of ions from the metal 
surface into solution, which forms species that result in the 
formation of an oxide layer that adheres to the metal surface. 
The Mg (OH)2 layer fo rmed on the metal surface is slightly 
soluble and reacts with chorine ions to form highly soluble 
magnesium chloride and hydrogen gas[94, 95]. When the 
oxide layer fully covers and seals the metal surface, it forms 
a kinetic barrier or passive layer that physically limits or 
prevents further migration of ionic species across the metal 
oxide solution interface. 
The corrosion of Mg in an aqueous physiological 
environment can be expressed in the following equations. 
The primary anodic reaction is expressed by the partial 
reaction presented in equation (1), at the same time the 
reduction of protons is expressed by the partial reaction 
occurring at the cathode (2). 
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Anodic reaction: Mg → Mg2- + 2e-          (1) 
Cathodic reaction: 2H2O + 2e- → 2OH-  + H2      (2) 
Another undesirable consequence of the corrosion process 
in Mg and its alloys is the formation of hydrogen gas. The 
rapid formation o f hydrogen gas resulting from the rich 
chorine environment produces subcutaneous gas bubbles, 
which generally appear within the first week after surgery 
and then disappear after 2 to 3 weeks[92]. During the init ial 
gas formation a subcutaneous needle can be used to draw off 
the gas. In 2007, Song postulated that a hydrogen evolution 
rate of 0.01 ml/cm2/day can be tolerated by the human body 
and does not constitute a serious threat[96]. 
If the Mg corrosion rate can be regulated so that the 
hydrogen evolution rate is below this value, then the implant 
will not create a gas threat. The reactions of solid Mg and the 
Mg (OH)2 layer with chorine ions in the aqueous 
environment are presented in equations (3) and (4). 
Solid Mg: 
Mg (s) + 2Cl-(aq) → MgCl2 + 2e-             (3) 
Mg (OH)2 layer: 
Mg (OH)2 (s) + 2CL-(aq) → MgCl2 + 2OH-     (4) 
The general reaction of the corrosion process is presented 
in equation (5). 
Mg (s) + 2H2O (l) → Mg (OH)2 (s) + H2 (g)      (5) 
Corrosion in the aqueous environment of the body is not as 
straight forward as corrosion in the industrial environment. 
This is due to the corrosion rate being influenced by a variety 
of other factors such as: 1) the pH of body fluids; 2) 
variations in the pH value; 3) concentration of ions; 4) the 
presence of proteins and protein adsorption on the 
orthopaedic implant; and 5) the influence of the surrounding 
tissues[97, 98 and 99]. 
2.2. Types of Biological Corrosion  
An important property of the oxide layer is its ability to 
remain fixed to the metal surface during a variety of 
mechanical loading situations. If the oxide layer ruptures 
during mechanical loading it will expose the pure Mg 
substrate to body fluids which will result in  further corrosion. 
The clinical repercussion of the corrosion process is the loss 
of mechanical strength and the ultimate failure of the implant. 
Typical forms of Mg corrosion encountered within the body 
environment are d iscussed in the following sections. 
2.2.1. Galvanic Corrosion 
Galvanic corrosion takes place between two dissimilar 
metals, each with a different electrochemical potential, when 
they are in contact in the presence of an electrolyte which 
provides a pathway for the transfer of electrons. The less 
noble metal becomes anodic, corrodes and produces a build 
up of corrosion by-products around the contact site. For 
example, if gold screws are used to attach an Mg plate to 
bone during reconstructive procedure, the resulting 
electrolytic effect  of the body fluids (serum or interstitial 
flu id) would preferentially attack the Mg plate; see Figure 
1[100]. Therefore, it would be good design practice to use 
metals with similar electrochemical properties when 
designing implant devices. For example, the fixation screws 
used to attach an Mg plate during a bone reconstruction 
procedure should be made of a titanium (Ti) alloy, since Ti is 
the closest metal to Mg in the electrochemical series. Mg is 
the most reactive metal in the electrochemical series and will 
always be the anode in any corrosion reaction[101]. 
Therefore, selection of Ti alloy fixation screws to secure the 
Mg plate ensures the lowest possible corrosion rate. 
Galvanic corrosion can also result from the presence of 
inter-metallic alloying elements or impurit ies present in the 
Mg matrix, see Figure 2. 
 
Figure 1.  Galvanic corrosion between dissimilar metals 
 
Figure 2.  Galvanic corrosion resulting from inter-metallic elements 
2.2.2. Granular Corrosion 
In many metal alloys, inter-granular corrosion can occur 
from the presence of impurities and inclusions which are 
deposited in the grain boundary regions during solidification. 
Following solidification, numerous galvanic reactions takes 
place between the metal matrix and the various impurities 
and inclusions. The ensuing corrosion rate at the various 
grain boundary regions exceeds that of the grains and results 
in an accelerated corrosion rate of the metal matrix.  
However, in the case of Mg alloys, inter-granular corrosion 
does not occur since the grains tend to be anodic, while their 
boundaries are cathodic in nature compared to the interior of 
the grains. The resulting grain boundary corrosion undercuts 
nearby grains which  subsequently fall out of the matrix[102]. 
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2.2.3. Pitt ing Corrosion 
Pitting corrosion of Mg results from the rapid corrosion of 
small-localized areas which damage the protective surface 
oxide layer; see Figure 3. This form of corrosion is more 
serious than other forms of corrosion since the surface pits 
are difficu lt to see due to the presence of corrosion products. 
The pits are small, highly corrosive and continue to grow 
downwards, perforating the metal matrix[103]. After init ial 
nucleation at the surface, the presence of impurit ies in the 
Mg alloy microstructure often assists in further corrosion due 
to the galvanic differences in the materials[104, 105]. The 
environment within the pit is very aggressive, with chlorides 
species from the body flu ids and Mg+ ions from anodic 
dissolution greatly aggravating the situation. In addition, the 
mouth of the pit  is s mall and prevents any dilution of the pit 
contents, which adds to the accelerating autocatalytic growth 
of the pit. During this process, electrons flowing from the pit 
make the surface surrounding the pit entrance become 
cathode-protected and the protective oxide layer is further 
weakened. Once pitting starts, an Mg component can be 
totally penetrated within a relatively short period of time and 
in the case of a biomedical implant, its load bearing capacity 
would be greatly  reduced to the point of failure. Another 
problem associated with pitting arises from localised 
increase in stress produced by the pit, which has the potential 
to form cracks[106]. The fo rmation of stress corrosion 
cracking and metal fatigue cracks in the pits can lead to 
failure of the implant during normal loading conditions. 
 
Figure 3.  Pitt ing corrosion site at the surface of a magnesium component 
 
Figure 4.  Crevice corrosion occurring between magnesium components in 
a body fluid environment 
2.2.4. Crevice Corrosion 
Crev ice corrosion is local contact corrosion that occurs 
between metal and metal/non metal components. For 
example, if a  magnesium plate is to be fixed in location by a 
set of screws with a small gap between the screw head and 
plate. The gap must have sufficient width to allow the flow of 
the body fluids through the gap and prevent any stagnant 
flow, see Figure 4. The stagnant flow results in the build up 
of Mg+ ions, with an Mg+ ion concentration gradient soon set 
up between the entrance and the dead end of gap. The 
subsequent corrosion cell then starts to attack the metal 
components of the implant[107]. 
2.2.5. Fretting Corrosion  
Fretting corrosion is the result of damage p roduced by 
metal components in direct physical contact with each other 
in the presence of small vibratory surface motions. The 
micro-motions are produced by normal every day activities 
experienced by the human body which result in mechanical 
wear and metallic debris between the surfaces of metal 
components making up the biomedical implant[108]. During 
daily activ ity, the micro-motions remove the passive surface 
layer o f the metallic  components in direct  contact, exposing 
fresh metal underneath. Then both the fresh metal surfaces 
and the metallic  surface debris undergo oxidation. The 
surface debris has a further detrimental effect by acting as an 
abrasive agent during subsequent micro-motions. The 
corrosion rate is dependent on the applied load, the resulting 
fretting motion, the microstructure of the metal o r metal 
alloys used in the implant and solution chemistry in the 
region around the fretting  zone[109, 110]. During the 
corrosion process metallic ions are produced which can form 
a wide range of organic-metallic complexes and some 
metallic implants can release toxic metallic ions such as 
chromium, cobalt and nickel. These harmfu l metallic ions 
significantly reduce the biocompatibility of the implant and 
solicit a major inflammatory response from the body’s 
immune system[25, 26, and 27]. In the case of magnesium, 
metallic  ions released during fretting, can be considered 
physiologically beneficial since these ions can be consumed 
or absorbed by the surrounding tissues, or be dissolved and 
readily excreted through the kidneys. Fretting corrosion is 
common in load bearing surfaces and is also capable 
initiat ing fatigue cracks in the fretting zone. Once formed the 
crack can propagate into the bulk of the metal matrix and can 
lead to the failure of the implant. 
2.2.6. Erosion Corrosion 
Erosion corrosion occurs from the wearing away of the 
metal surface or passive layer by the impact of wear debris in 
the body environment surrounding the implant. The metallic 
debris impacts on the surface of the implant, transferring 
energy into the region of the collision and plastically 
deforming the surface. During the deformation p rocess the 
surface becomes work harden to the point where the next 
impact exceeds the strain required fo r surface fracturing, 
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pitting or chip format ion. With the passage of time, the 
numerous impacts result in material loss from the metal 
surface[111]. For example, a femoral head of a 
Cobalt-Chromium implant will have numerous scratches 
after 17 years of implantation in a patient[112]. A ll 
bio-metals used in implants inevitably corrode at some fin ite 
rate when immersed in the complex electrolytic environment 
of the body; even Ti alloys with the lowest corrosion rate 
produce corrosion debris. The debris can significantly 
influence the wear behaviour and erosion resistant properties 
of the implant. However, the effects of erosion may not be 
noticed until there is a significant loss of metal which 
ultimately leads to the clinical failure of the implant.  
2.2.7. Stress Corrosion 
When an electrochemical potential is formed between 
stressed and unstressed regions of a metal implant under load, 
there is an increase in the chemical act ivity of the metal.  
This stress initiated corrosion mechanism effect ively 
increases the corrosion rate, usually by two to three times 
above the normal uniform rate. Th is usually results in the 
formation of s mall cracks that concentrate stress within the 
loaded implant, a mechanism know as stress corrosion 
cracking (SCC). Mg SCC can  occur in any load stressed 
implant immersed in the dilute chloride environment of the 
body fluids. SCC init iated cracks grow rapidly and extend 
between the grains throughout the metal matrix[113, 114]. 
The progress of SCC is also influenced by the strain rate 
resulting from the implant loading cycles and the presence of 
hydrogen gas produced by the corrosion process[115, 116]. 
Current research suggests that chloride ions produce pitting 
in the protective surface layer, which ultimately leads to a 
break down in the layer exposing the underlining Mg matrix 
to the electrolytic flu ids of the body environment. The 
resulting hydrogen diffuses into the stressed zone of the 
metal matrix ahead of the crack tip and allows the SCC crack 
to advance through the zone[117-119]. Fracture and failu re 
of the implant will occur when the SCC is below the normal 
operating stress of the implant. 
2.2.8. Corrosion Fatigue 
Corrosion fatigue is the result of a material being exposed 
to the combined effects of a cycling load and a corrosive 
environment[120]. In general, metal fatigue is the damage 
caused by the repeated loading and unloading of a metal 
component. The cyclic stress initiates the formation of 
microscopic cracks on the metal surface and also damages 
the protective passive layer. If there are any surface 
imperfections such as pores or pitting from corrosion, they 
become crack nucleat ion sites which can significantly speed 
up crack g rowth rates. In  the body’s environment the cracks 
become localized electrochemical cells that promote further 
corrosion. Mg in particular is susceptible to corrosion fatigue 
due to the presence of chloride ions in the body fluids. 
Corrosion within the crack promotes crack propagation and 
in combination with cyclic loading, the crack growth rate 
significantly increases. Eventually the loading stress exceeds 
the SCC threshold and the crack grows to a critical size 
resulting in the fracture of the metallic implant. The body 
environment can significantly reduce the fatigue life of Mg 
alloys, producing lower failure stresses and considerably 
shorter failure times. 
3. Magnesium and its Alloys 
For biomedical applicat ions, the composition of the 
material being considered is a crucial factor since many of 
the elements that make up commercially  available materials 
for industrial applications are extremely toxic to the human 
body. Therefore, in addition to meeting the mechanical 
properties needed for a particular biomedical applicat ion, the 
material must also be biocompatible. Ideally, a 
biodegradable biomedical device should be composed of 
materials or alloys that are non toxic or carcinogenic. It 
would also be very advantageous if the material was 
composed of elements and minerals already present and 
compatible within the body such as magnesium, calcium and 
zinc, see Tab le 3. Furthermore, the material should have a 
controllable d issolution rate or slow corrosion rate that 
permits the biomedical device or implant to maintain its 
mechanical integrity until the surrounding tissues heal and 
are capable of carrying the load once again. After the healing 
process has taken place, the load bearing properties of the 
biomedical implant  are no longer required  and the implant 
material should then be able to slowly dissolve away. 
Furthermore, the resultant by-products of the degradation 
process should be non-toxic; capable of being consumed or 
absorbed by the surrounding tissues, or being dissolved and 
readily  excreted through the kidneys. Thus, for Mg and its 
alloys to be used as an effective biodegradable implant it is 
necessary to control their corrosion behaviour in the body 
flu id environment[121]. 
3.1. The Influence of Alloying Elements on Physical and 
Mechanical Properties 
There are three major groups of Mg alloys: the first group 
consists of pure Mg; the second group consists of aluminium 
(Al) containing alloys such as AZ91, AZ31 and rare earth 
elements (RE) such as AE21; and the final group consists of 
the Al free alloys such as Mg-Ca, W E, MZ and WZ. The use 
of alloying elements such Al, Ca, Li, Mn, Y, Zn, Zr and RE 
in Mg alloys can significantly  improve the physical and 
mechanical properties of the alloy by: 1) refin ing the grain 
structure; 2) improving the corrosion resistance; 3) form 
inter-metallic phases that can enhance the strength; and 4) 
assist in the manufacture and shaping of Mg alloys. 
Impurit ies commonly found in Mg alloys are Be, Cu, Fe 
and Ni and the levels of theses impurities are restricted to 
within  specific limits during the production of the alloy, see 
Table 3. The range of acceptable levels for Be ranges from 2 
to 4 ppm by weight, while Cu is (100-300 ppm), Fe (30-50 
ppm) and Ni (20-50 ppm)[122]. Since both Be and Ni are 
carcinogenic, their use in b iomedical applications should be 
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avoided as alloying elements. While elements such as Ca, 
Mn and Zn are essential trace elements for human life and 
RE elements exhib iting anti-carcinogenic properties should 
be the first choice for incorporation into an alloy. Studies by 
Song have suggested that very small quantities of RE 
elements and other alloying metals such as Zn and 
Manganese (Mn) could be tolerated in the human body and 
could also increase corrosion resistance[123]. Mn is added to 
many commercial alloys to improve corrosion resistance and 
reduce the harmful effects of impurit ies[124]. Mg alloys 
containing rare earth elements have also been found to 
increase the resistance to the flow of Mg2+ ions out of the Mg 
matrix via the Mg oxide layer[125]. During the degradation 
process the RE elements remained localised in the corrosion 
layer, which also contained high levels of both calcium and 
phosphorous. Also during this period a thin amorphous 
calcium phosphate layer formed  over the surface of the oxide 
layer[92, 126]. 
Recent studies by Witte et al. have investigated the 
degradation behaviour of Mg based alloy rods and polymer 
based control rods[poly (lactic acid)] in animal models. 
Rods of 15 mm d iameter and 20 mm long were inserted into 
the femur of guinea p igs and the rods degradation profile 
monitored. The percentage compositions by weight of the 
Mg alloys investigated consisted of two alumin ium-zinc 
alloys composed of 3% Al and1% Zn  {AZ31} and  9% Al 
and 1% Zn {AZ91} with the balance of the alloys composed 
of pure Mg. In addition two RE alloys were studied, the first 
consisted of 4% yttrium and a 3% rare earth mixture 
composed of neodymium, cerium and dysprosium {W E43} 
and the second composed of 4% lithium, 4%, aluminium and 
a 2% rare earth mixture o f cerium, lanthanum, neodymium 
and praseodymium {LAE442}[92, 127]. The implants were 
harvested at 6 and 18 weeks, with complete implant 
degradation occurring at 18 weeks. During this time 
radiographs were regularly  taken, while a 
micro -tomography-based technique using X-ray synchrotron 
radiation was used to characterize the implant’s degradation 
process. All Mg based alloy implants were found to be 
beneficial and promoted new in situ bone tissue format ion, 
while the polymer control rods produced a less significant 
effect. The LAE442 alloy had the greatest resistance to 
corrosion, while the other alloys all had similar, but lower 
values of corrosion resistance and degraded at similar 
rates[92]. 
While Mg is potentially an ideal biocompatible implant 
material due to its non-toxicity to the human body, the safe 
long term use of an Mg based alloy needs to be carefully 
studied. Magnesium based alloys have also been used in vivo; 
for example an  AZ91 alloy rods were implanted into the 
femur of a number of rabbit models and the subsequent 
analysis revealed that after 3 months the implant had 
degraded and been replaced by new bone tissue[128, 129]. 
At the end of this degradation process most of the alloying 
elements such as Al would have been released into the bodies 
of the rabbits. The long term health effects on the rabbits are 
unknown, but in the case of the human body, the release of 
Al into the body will create undesirable health 
problems[130]. In humans, Al is a neurotoxicant and its long 
term accumulation in brain t issues has been linked to 
neurological disorders such as Alzheimers disease, dementia 
and senile dementia[131]. In addition, the administration of 
RE elements such as cerium, praseodymium and yttrium has 
resulted in severe hepatotoxicity in rats[132]. Furthermore, 
using heavy metal elements as alloying components are also 
potentially toxic to the human body due to their ability to 
form stable complexes and disrupt the normal molecular 
functions of DNA, enzymes and proteins[133]. Therefore, 
there is a definite requirement to carefully select alloying 
elements that are non-toxic to the human body, see Table 4. 
Non-toxic alloying elements such as Ca[134] and Zr[135] 
have the potential to significantly improve the corrosion 
resistance of the Mg alloy and reduce the degradation rate to 
make the Mg metal alloy a viab le implant material[33]. 
Table 3.  Chemical analysis of alloying elements for a selection of magnesium alloys 
Alloy Nominal element component (wt. %) Maximum values of trace elements (wt. %) 
 Al Zn Mn Ca Li Nd Zr Y  
AZ31 3.5 1.4 0.3 - - - - - Fe (max 0.003), Cu (0.008), Si (1.2), Ni (0.001) and Be (5 – 15 ppm) 
AZ91 9.5 0.5 0.3 - - - - - Fe (max 0.004), Cu (0.025), Si (0.05), Ni (0.001) and Be (5 – 15 ppm) 
AM60 6.0 0.2 0.2 - - -   Fe (max 0.004), Cu (0.008), Si (0.05), Ni (0.001) and Be (5 – 15 ppm) 
LAE442 4.0    4.0 2.0   Contains some heavy metal rare earth elements 
WE43 - - - - - 3.2 0.5 4.0 Contains some heavy metal rare earth elements 
Note: Table compiled from references[92, 93, 216, 217 and 218] 
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Enhancement to Mg Matrix Pathophysiology Toxicology 
Aluminium 
Rapidly diffuses through Mg 
matrix, and acts as a 
passivating element and 
improves corrosion 
resistance. 
Improves die cast-ability 
 
Blood serum level 2.1-4.8 µg/L 
Tends to diffuse out of Mg matrix 
Neurotoxic (influences function of the 
blood brain barrier) 
Linked to Alzheimer’s disease 
Accumulates in amyloid fibres/brain 
plaques. 
Accumulates in bone tissue/decreases 
osteclast viability 
Calcium 
Adding to improve 
corrosion resistance in 
Mg-Ca alloys. 
Blood serum level 0.919-0.993 mg/L. - 
Levels controlled by Homeostatis of 
skeleton. Abundant mineral that is 
mainly stored in bones and teeth. 
Activator/stabilizer of enzymes. 
Involved in blood clotting 
Metabolic disorder of calcium levels results 
in the formation of excess calcium in the 
kidneys (stones). 
Copper 
Can increase strength of Mg 
casts, however, it  also 
accelerates corrosion rate 
when exposed to a NaCl 
medium. 
Blood serum level 74-131 µmol/L 
Essential trace element 
Excessive amounts of Cu have been linked 
to neuro-degenerative diseases. 
Can produce cellular cytotoxicity. 
Manganese 
Adding to reduce the 
harmful effects of impurities 
and improve corrosion 
resistance 
Blood serum level <0.8 µg/L 
Essential trace element 
Influences cellular functions/immune 
system/blood clotting/bone growth. 
Influences metabolic cycle of 
lipids/amino acids and carbohydrates 
Excessive amounts of Mn can produce 
neurological disorder. (manganism) 
Lithium Improvement in corrosion resistance 
Blood serum level 2-4ng/g 
Used in drugs to treat psychiatric 
disorders 
Overdose causes central nervous centre 




Improvement in corrosion 
resistance 
Many rare earth elements have 
anticancerogenic properties and are used 
in the treatment of cancer. 
Accumulate in the liver and bone 
Zinc 
Improves yield stress, Mg 
alloys containing Zn have an 
Elastic Modulus similar to 
bone. 
The presence of Zn can 
reduce hydrogen gas 
evolution during 
bio-corrosion. 
Blood serum level 12.4-17.4µmol/L 
Essential trace element 
Essential to enzymes and immune 
system 
In high concentrations is neurotoxic and can 
hinder bone development. 
Note: Table compiled from references[122, 134, 213, 222, 223, 224, 225, 226 227 and 228] 
4. Surface Modifications and Treatment 
Processes for Biomedical Mg Alloys  
The high degradation rate of Mg and Mg alloy implants in 
the human physiological environment would result in the 
reduction of mechanical integrity of the implant before the 
bone tissues had sufficient time to heal[26]. There are two 
methods of reducing the degradation rate; the first, which 
was discussed in Section 3, involved alloy ing Mg with 
biocompatible elements that can resist the corrosion process. 
The second method is d iscussed in this section and involves 
the surface modification of the implant, through a treatment 
process that provides a resistive barrier against the body 
environment. An important factor that needs to be taken into 
account before any surface treatment is investigated is the 
healing or regenerative processes of bone and other 
associated body tissues. The healing process consists of three 
phases; inflammatory, reparat ive and remodelling.  
The in itial inflammatory phase usually lasts between 3 to 
7 days and this is the natural response of the body’s immune 
system to the presence of the biomedical device or implant. 
The reparative phase usually takes 3 to 4 months, during 
which t ime integration of the implant with the new and 
regenerated tissues takes place. The final remodelling phase, 
which is the longest phase, can take from several months to 
years to complete[136]. For Mg to be an effective 
bio-absorbable implant the degradation rate must be slow 
enough for the healing process to take place and the new 
tissues have sufficient time to provide their own structural 
support before the structural integrity of the implant is 
compromised. The minimum period for this to take place is 
at least 12 weeks[26]. Unfortunately, Mg alloys can 
completely degrade before the end of this timeframe and as a 
result there is a need to reduce the biodegradation rate. The 
bulk propert ies of Mg based alloys dictate its mechanical 
properties, but it is the surface properties that influence the 
interaction between the metal and the surrounding tissue 
environment of the body. As a consequence, surface 
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modifications and treatments can have a significant ro le to 
play in  governing the degradation rate of the implant. To date, 
numerous surface modification techniques have been 
developed to change the surface characteristics of 
biomaterials. Many of these methods have been applied to 
modifying the surface p roperties of Mg bio-alloys. A brief 
overview of some of these surface modificat ion processes 
are presented in the following the four sections. 
4.1. Mechanical Modifications to Induce Surface and 
Subsurface Properties  
The surface structure of an implant is very important, 
since it is the init ial response of the surrounding tissues to the 
surface of the implant material that determines whether or 
not there is effective t issue-biomaterial integration. Studies 
of conventional types of permanent implant materials have 
shown that surface roughness can influence both cell 
morphology, cell growth and implant integration. In addition, 
modification of the surface topography by the physical 
placement of grooves, columns, pits and other depressions 
can influence cell orientation and attachment[137-139]. In 
the case of Ti alloys, surface modifications such as grooves, 
surface sand blasting and acid etching has revealed that 
grooved surface features provide superior cell attachment 
and promote greater cell pro liferation than roughen 
surfaces[140]. For Mg alloys, the influence of different 
mechanical p rocessing operations during fabricat ion has the 
potential to great ly influence surface and subsurface 
properties[141, 142]. 
Mechanical processing techniques involve operations 
such as rolling, shot peening, and milling. In  the case of 
milling, at low cutting speeds, the surface formed by honed 
cutting tools tends to produce a rougher surface than those of 
sharp cutting tools. Also, during milling and similar metal 
chip removing processes, the exact effect on the underlining 
sub-surface is not fully understood[143], while chip removal 
from the surface during machining can direct ly influence the 
surface topography[144]. Besides machining techniques for 
chip removal, the use of rolling operations can also generate 
high passive forces acting normal to the surface, which can 
induce work hardening of the sub-surface. During the rolling 
operation the sub-surface grain structure is changed by the 
compressive stresses induced and the resultant 
micro -topography of the surface is significantly 
changed[145]. A recent study by Denka et al. has revealed a 
significant reduction in the corrosion rate (a factor of 100 
was achieved in corrosion studies) of an Mg-Ca alloy that 
was deep-rolled, compared to the same alloy that was 
mach ined[146]. The presence of residual compressive 
stresses after ro lling also has the advantage of reducing 
micro-crack formation from pre-existing crack nucleation 
points within the substrate. The suppression of crack 
formation is also an important factor in improving the fatigue 
life cycle of a material being considered fo r b iomedical 
applications[146, 147]. 
The importance of surface and sub-surface treatments on 
Mg alloy implants was recently investigated by Von Der 
Hoh et al.[148]. In their study three surface machining 
treatments were applied to an Mg-Ca (0.8 % wt calcium) 
alloy. The alloy was used to make three different geometric 
sample types. The first test sample was a machined 3 mm 
diameter s mooth cylinder, the second was like the first, 
except that it was sand blasted for 30 s using particles 
ranging in size from 300 to 400 µm and the final surface 
topography was a threaded cylinder. The smooth cylinders 
were machined with no fu rther surface treatment, so they 
retained the micro-surface topography produced by the 
cutting tool. After 6 months of in vivo implantation in adult 
New Zealand white rabbits, the smooth cylinders revealed 
good integration with the surrounding tissues and also had 
the least structural loss. The sand blasted cylinders had the 
greatest material loss with the init ial cylindrical shape 
completely consumed, while the threaded cylinders ranged 
between these two extremes. The results indicated that the 
smoother micro-topographic surface features of the cylinders 
were suitable for resorbable Mg alloys, while the test 
samples with the rougher surfaces promoted higher 
degradation rates. The results of this study clearly indicated 
that differences in surface roughness of the test samples 
could significantly influence the in vivo degradation rates. 
The study also highlighted the need for further investigation 
into the effects of different surface modifications on other 
biocompatible Mg alloys. 
4.2. Physical and Chemical Modifications 
From an engineering point of view, the most effective way 
to prevent corrosion is to coat the metal component with a 
protective barrier that effect ively isolates the metal from the 
surrounding environment. To be effective against corrosion, 
the protective coating must be uniform, well adhered and 
free from any imperfections such as pits, scratches and 
cracks. The major problem with Mg, as mentioned earlier, is 
its chemical reactivity when exposed to air or an aqueous 
environmental which results in the formation of an 
oxide/hydroxide layer over the metal surface. The presence 
of the oxide/hydroxide layer will have a detrimental effect on 
the ability of the coating to adhere to the metal surface and 
form a unifo rm protective layer. Therefore, surface cleaning 
and a suitable pre-treatment o f the metal surface is a crucial 
factor in achiev ing an effective surface coating. 
4.2.1. Physical Vapour Deposition (PVD) & Chemical 
Vapour Deposition (CVD)  
The PVD process involves the deposition of thin layers of 
metal and metal alloys from atoms or molecules from the 
vapour phase onto a substrate surface. During the process a 
metal or metal alloy is heated in vacuum chamber until it 
evaporates and then the subsequent vapour condenses onto 
the cooler substrate. This process has been successfully used 
on a variety of metals, but in  the case of Mg there are a 
number o f problems  to overcome. For example, in most PVD 
processes the substrate temperature range is usually between 
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400 and 550 oC, but in the case of Mg the substrate 
temperature must be kept below 180 o C for material stability 
reasons. The lower substrate temperature of Mg also 
influences the adhesive and corrosion resistance properties 
of the coating[149, 150]. The PVD process has successfully 
deposited binary alloys such as Mg-Ti, Mg-Zr and Mg-Mn 
along with other less biocompatible and toxic alloys.  The 
subsequent corrosion studies have revealed that the 
binary-alloyed surface coating were capable of increasing 
the corrosion resistance of the various Mg alloys[151-153]. 
The chemical vapour deposition process has also been used 
to produce a variety of coating processes that can create a 
protective coating or modify the existing Mg alloy surface. 
During the deposition of a solid material from the vapour 
phase onto a (usually) heated substrate a chemical reaction 
over the surface takes place. This results in  changes to the 
sub-surface of the substrate, which chemically modifies the 
surface properties. For example, the deposition of diamond 
like carbon (DLC) films on metallic  implants can improve 
the surface properties of the implant, thus making it 
biocompatible with the surrounding body tissues[154]. 
4.2.2. Ion Implantation and Plating 
Ion implantation consists of bombarding the surface of a 
substrate with  ionized  particles. The ionized part icles 
penetrate the surface and become embedded in the 
sub-surface of the substrate. The ionized particles soon 
neutralize in the interstitial positions within the grain 
structure forming a solid solution. During this process 
physiochemical changes take place in the sub-surface of the 
substrate, while the bulk properties of the substrate remain 
unchanged. To date there have been relatively few studies 
carried out that have used ion implantation to enhance the 
surface properties of Mg alloys. A recent study by Liu  et al. 
examined the corrosion behaviour of surgical AZ91 after it 
was subjected to Ti ion implantation[155]. The study 
revealed that a compact surface oxide layer was formed, 
which was predominantly composed of TiO2 with a smaller 
amount of MgO. Subsequent testing in simulated body flu id 
at 37 ± 1℃  revealed that the corrosion resistance of ion 
treated AZ91 alloy was improved significantly. In a similar 
study by Fang et al. the corrosion behaviour of a new 
medical grade Mg-Ca alloy was examined before and after 
Zn ion implantation[156]. The results revealed that after ion 
implantation, the Zn had improved the surface hardness and 
elastic modulus of the alloy. The surface oxide layer fo rmed 
during corrosion testing in simulated body fluid enhanced 
the Mg-Ca alloys corrosion resistance. However, Wan et al. 
examined a Mg-Ca alloy before and after Zn ion 
implantation, the results found that the ion-implanted 
substrates had a lower corrosion resistance than the untreated 
substrates[157]. Subsequent analysis of the results suggests 
that Zn was an unsuitable metal for ion implantation with 
Mg-Ca alloys for b iomedical applicat ions. 
Ion plating is a technique that deposits noble metal ions 
onto a less noble metal substrate to form a dense and 
well-adhered layer. The plating layers improve surface 
properties such as topography, roughness, surface chemistry 
and wear resistance. Zhang et al. used this technique to plate 
a pure Mg substrate with Ti ions and then subsequently 
studied its corrosion behaviour in a 0.9 wt % NaCl 
solution[158]. The results not only revealed a substantial 
improvement in corrosion resistance, but also found that an 
interfusion layer had formed between the Ti coating and the 
Mg substrate. 
4.2.3. Thermal Spray Coatings  
During th is coating process, materials such as metals, 
metal alloys, ceramics, polymers and composites are feed 
(powder or wire form) into a gun. The material is then heated 
to a molten or semi molten state within a gas stream. The 
resulting micrometer size droplets are accelerated in  the gas 
stream, which is directed towards the surface of the 
substrate[159]. This technique was successfully used by 
Zhang et al. to deposit an Al layer on an  AZ91D 
substrate[160]. To  ensure adhesion of the coating to the 
substrate, a post heat treatment process was carried out 
450℃ . There was significant diffusion of Al and Mg around 
the interface of the coating, which enhanced both the 
corrosion resistance and anti-wear properties of the coating. 
The disadvantage of using an Al coating on the AZ91D 
substrate for a possible biomedical implant applicat ion is the 
negative effect of Al3+ ions being released into the 
surrounding tissues during subsequent corrosion. Ceramic 
coatings such hydroxyapatite (HAP), TiO2, Al2O3, and ZrO2 
have also been successfully applied to Ti alloys to improve 
their corrosion resistance, wear resistance and 
biocompatibility[161]. However, in a study by Zeng et al., 
thermally sprayed TiO2 onto an Mg alloy (AM60) revealed 
that the subsequent coating showed no improve in its 
corrosion resistance compared to the untreated Mg alloy 
when they were both immersed in Hanks’ solution[162]. The 
study also revealed that galvanic corrosion occurred between 
the surface of the Mg alloy and the coating layer, which 
effectively reduced any protective properties offered by the 
coating. This highlights the weakness of thermally sprayed 
ceramic coatings which have rough surfaces, high porosity 
and poor adhesion properties[163]. 
4.2.4. Laser Surface Melting, Alloying and Cladding 
The high-density energy of a laser beam can be effectively 
used to modify the surface region of Mg alloys. The surface 
region of the alloy can be melted to create a meta-stable solid 
solution. This is then followed by rapidly cooling the 
substrate, which results in  the refinement of the surface 
microstructure. This technique can also be used to improve 
the surface properties of an  Mg alloy substrate by melting  a 
metallic coating and the underlin ing sub-surface. During the 
rapid melting process both the coating and sub-surface mix 
before re-solidifying during subsequent cooling to form a 
new surface alloy which coats the bulk of the substrate. 
Furthermore, if the appropriate alloying metals are 
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incorporated into this surface modificat ion technique it  is 
possible to significantly improve surface properties such as 
corrosion resistance[164, 165]. For example, improved 
surface properties of a Mg alloy (AZ91) have been achieved 
with the dispersion of hard metallic part icles such as TiC and 
SiC in the molten pool generated by laser melting[166, 167]. 
Also, laser cladding of an Al-Si alloy onto a number of Mg 
alloys such as AS41, AZ91 and W E54 have also been 
attempted, but unfortunately, the surface properties were not 
significantly improved[168, 169]. 
4.3. Wet Chemical Processes  
4.3.1. Electrochemical Deposition of Metallic Coatings  
The corrosion resistance of Mg and its alloys can be 
increased by an electroplating technique. In this technique a 
metal salt is reduced in solution to its metallic  form, the 
electrons for reduction are supplied from an  external source 
and the resulting metallic ions are deposited on to the surface 
of the substrate. However, most metals are more 
electrochemically noble than Mg, which can cause serious 
problems if there are any imperfect ions in the deposited layer.  
Such imperfections will expose the underlin ing substrate and 
result in the format ion of s mall localized areas of corrosion. 
The corrosion sites form h ighly corrosive pits that tunnel 
down into the Mg substrate and seriously weaken the 
substrate[141]. From an industrial point of view, 
electroplating is a highly effect ive technique for coating Mg 
and its alloys with metallic coatings such as nickel, ch rome 
and alumin ium coatings[142]. These coatings have good 
mechanical properties and provide effective corrosion 
protection. Unfortunately, these metals are also harmful to 
human t issues, which make them h ighly unsuitable for 
biomedical applicat ions. 
4.3.2. Chemical Conversion Coatings 
Chemical conversion coatings are formed  by chemically  
treating the surface of Mg and Mg alloys to produce a thin 
outer coating of metal oxides, phosphates or other 
compounds that are chemically bonded to the surface[170]. 
The conversion coating acts as protective barrier that isolates 
the substrate from the surrounding environment and prevents 
the corrosion. 
Industrially, there are several different types of conversion 
coatings such as chromate, phosphate/permanganate, rare 
earth, stannate and hydrides. Many of the processes used to 
produce conversion coatings involve the use of toxic 
materials that are detrimental to human health. For example, 
the presence of hexavalent chromium (Cr6+), that is used in 
chromate coatings. 
An alternative treatment to chromate conversion coatings 
are: 1) phosphate; 2) phosphate-permanganate; and 3) 
stannate coatings. All three of these conversion treatments 
have comparable corrosion resistant properties to those of 
chromate t reatments. Xu et  al. have investigated the 
behaviour of a phosphate treatment on an Mg alloy 
(Mg-Mn-Zn) that was subsequently immerged in a simulated 
body solution (SBF). During the treatment process a 
biocompatible brushite layer[CaHPO4.2H2O] was formed on 
the surface of the substrate. Subsequent immersion in  SBF 
revealed that the brushite layer transformed into a coating of 
HAP, with the excess phosphate ions being released into the 
surrounding environment. The released phosphate ions were 
also found to neutralize the alkalizat ion effect produced by 
the corrosion process. The treatment process did not prevent 
corrosion, but it did significantly slow down the degradation 
rate[171]. And a phosphate-permanganate process 
developed by Han et al. using Mn3(PO4)2 was ab le to 
produce a resilient surface coating on a Mg alloy (AZ31D) 
that was self healing in saline solutions[172]. While a 
stannate treatment developed by Gonzalez-Nunez et al. was 
able to deposit a 2 to 3 µm thick layer of MgSnO3 on an Mg 
alloy (ZC71). The coating was adherent, continuous, and 
crystalline which produced a passivating effect on the 
substrate surface[173]. Unfortunately, no degradation rate 
data was reported, indicating that more studies are needed to 
indeed gauge the effectiveness of this process for in vivo 
applications. 
Magnesium fluoride (MgF2) conversion coatings on Mg 
alloys have produced mixed results in providing corrosion 
protection. Degradation studies carried out by Zeng et al. 
reported that an MgF2 conversion layer formed on an Mg 
alloy (AZ31) provided marg inal corrosion resistance in a 0.9 
wt % NaCl solution[174]. While in  a similar study Hassel et 
al. found that a conversion layer of MgF2 formed on an Mg 
alloy (ZM21) could provide reasonable corrosion 
resistance[175]. And an in vivo study carried out by Witte et 
al. revealed that a  conversion layer thickness between 150 
and 200 µm formed on the surface of a RE based Mg alloy 
(LAE442) was able to reduce the degradation rate and reduce 
the release of alloying elements[176]. In a similar study by 
Gao et al., the feasibility of forming RE conversion layers on 
pure Mg to improve corrosion resistance was examined[177]. 
The two RE elements under investigation were Ce and Y, 
with each element being used individually  to form a surface 
treatment solution. The first solution contained CeCl3 which 
formed a conversion layer consisting of Mg (OH)2, CeO3 and 
MgO, while the second solution contained Y(NO3)2 which 
formed a conversion layer consisting of Mg (OH)2, Y2O3 and 
MgO. The study revealed that the second conversion layer 
had improved corrosion resistance compared to the first. 
However, both coating provided limited corrosion resistance 
due to their thin thickness and soft structure, which was 
incapable of withstanding minor mechanical damage. 
Furthermore, both the toxico logy and metabolic pathways 
within the human body of RE elements such as Ce and Y are 
still unclear and need to be fully investigated before they can 
be used in biomedical applications. 
4.3.3. Calcium Phosphate Surface Coatings 
A more biocompatible form of conversion coating can be 
derived from a variety of calcium phosphate compounds. In 
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particular, HAP[Ca (PO4)6(OH)2], which has been widely 
used as a bone substitute and replacement in several 
biomedical applicat ions[178-180]. There are three major 
advantages in using HAP in hard tissue engineering 
applications: 1) it has good biocompatibility and bioactivity 
properties with  respect to bone cells and  other body tissues;  
2) it has a slow biodegradability in situ; and 3) it offers good 
osteoconductivity and osteoinductivity capabilit ies[181, 
182]. These properties are very important because bone 
tissue constantly undergoes remodelling, a process in which 
bone tissue is simultaneously replaced and removed by the 
bone cells, (osteoblasts and osteoclasts respectively). It  is 
these advantages that make HAP and TCP (tri-calcium 
phosphate) compounds attractive for coating metallic 
orthopaedic implants. In this application, both HAP and TCP 
coatings promote bone formation which enhances bonding 
between the implant and the surrounding tissues. 
It is also due to these positive biolog ical responses within 
the human body that has made calcium phosphate coating an 
attractive option for potentially reducing the biodegradation 
rate of Mg orthopaedic implants. Several techniques have 
been used to deposit calcium phosphate coatings onto Mg 
substrates, these range from anodization[183], b io-mimet ic 
co at ings[1 84- 18 6], ele ct ro- de posi t ion[1 87, 18 8], hydrothermal
[189] and wet chemical methods[190, 191]. 
Xu et al. has investigated using an immersion technique 
that involves soaking an Mg-Mn-Zn alloy in an alkaline 
solution to form a b rushite (CaHPO4.2H2O) surface coating. 
Unfortunately, the layer formed was porous and did not 
prevent corrosion in a simulated body fluid. However, the 
degradation rate was significantly reduced and provided the 
Mg alloy substrate with reasonable protection against the 
corrosive effects of the simulated body flu id. The study also 
found that the brushite coating was able to improve the 
surface biocompatibility of Mg alloy substrate, since the 
brushite coating transformed into a HAP phase with time. 
Also during this transformation, acid ic phosphate ions were 
released into solution, which  tended to have a neutralizing 
effect on the alkalizat ion process[192]. Furthermore, the 
surface treatment enhanced the bioactivity of the Mg-Mn-Zn 
alloy and promoted bone format ion[193]. 
A similar calcium-phosphate coating was produced by 
Wang et al., which involved immersing a Mg substrate into a 
solution containing Ca and P[Ca (NO3)2 and Na2HPO4] to 
create a di-calcium phosphate di-hydrate (DCPD) surface 
layer[194]. The DCPD layer was effective in providing 
protection for the Mg substrate during the first 21 days of 
immersion in a simulated body fluid.  
Recently, Yanovska et al. investigated the influence of 
low magnetic fields during a one-step dipping technique 
[195]. The involved dipping a Mg substrate into an aqueous 
solution containing Ca (NO3)2.4H2O and Na2HPO4.12H2O. 
Deposition of both DCPD and HAP phases under the 
influence of magnetic fields lead  to crystal orientation during 
the formation of the phases. The technique also produced 
coatings with enhanced corrosion resistance, which in turn 
reduced the degradation rate[195]. In an alternative method, 
Song et al. used an electro-deposition technique to produce 
three types of coating namely; DCPD, HAP and fluorapatite 
(FHA). The study found the FHA coating had long-term 
stability and remained intact even after 1 month of 
immersion in a simulated body fluid and provided effective 
corrosion resistance to the Mg alloy[196]. 
4.3.4. Alkali Heat Treatments 
Heat treatment can be a beneficial way of improving the 
microstructure and enhance the surface properties of Mg and 
Mg alloys. The corrosion behaviour and cytotoxicity of 
alkali heat-treated pure Mg samples immersed in simulated 
body fluid (SBF) were investigated by Li et al.[197]. The 
samples for treatment were p laced into a super saturated 
NaHCO3-MgCO3 solution and then heat-treated. SBF 
solutions with and without chloride ions were used to study 
the influence of chloride ions on the corrosion behaviour of 
treated Mg samples. A ll the treated samples showed a 
significant improvement in corrosion resistance in both SBF 
(Cl-) and SBF solutions compared to the untreated Mg 
samples. In  addition, after 14 days of immersion in  the SBF 
flu ids, a calcium phosphate compound with  a molar ratio of 
1.858 was detected on the surface of the samples. While the 
subsequent cytotoxicity testing revealed no signs of 
morphological changes in the cells and no inhibitory effect 
of the surface treatments on cell growth could be detected. 
In a similar study by Liu et al., the corrosion behaviour of 
a heat-treated Mg-Al alloy (AZ63) immersed in a SBF 
solution for 14 days was investigated[198]. During heat 
treatment (solution treatment at 413 o C for 24 h followed by 
aging at 216℃  for intervals of 1 h, 5.5h and 12 h), the 
microstructure of the Mg-Al alloy changes as the Al atoms in 
the alloy diffuse towards the grain boundaries and 
subsequently precipitate out of solution to fo rm the β phase. 
And as a consequence of the diffusion process (Aging), the 
concentration of Al atoms remain ing in  the matrix (α phase) 
decreases and results in the matrix having a reduced 
corrosion rate. In addition, the study found that samples 
microstructure significantly influenced the overall  
corrosion morphology. For example, the surface of the 
untreated samples displayed deep and uniform corrosion, 
while the surface of the treated samples had only shallow 
pitting[198]. 
4.3.5. Anodization  
The anodization of magnesium is an electro-chemical 
process that changes the surface chemistry of the metal, v ia 
oxidation, to produce a stable anodic oxide layer. The 
structure of this layer is characterized  by a thin  barrier layer 
at the metal-oxide interface, fo llowed by a less dense porous 
oxide layer. The porous layer can d isplay a variety of 
different structures and properties which are dependent on 
the composition, substrate micro-structure and processing 
parameters[142]. The processing parameters that influence 
oxide layer formation include: 1) the type, temperature and 
concentration of electrolyte; 2) current density; and 3) the 
applied anodization voltage. These parameters can also 
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significantly influence the resulting corrosion behaviour of 
the substrate[199]. The anodization process can also produce 
an oxide layer consisting of pores, whose size and density is 
dependent on the selection of the appropriate processing 
parameters. Industrially, porous oxide layers are usually 
coloured and then sealed or form part of a pre-treatment 
process prior to painting or coating. Many of the industrial 
coating and surface treatments used on anodized Mg alloy 
components to reduce corrosion are toxic to the human body.  
And as a result, research efforts have focused on searching 
for biocompatib le surface treatments and process that are 
non toxic. For example, Hiromoto et al. have studied the 
effects of controlled calcium phosphate (Ca-P) precipitation 
on pure Mg substrates by anodization and then thermally 
treating the substrates in an autoclave[200]. After thermal 
treatment, the subsequent immersion studies in Hanks’ 
solution revealed that the Ca-P coated substrates had very 
litt le corrosion[201]. The advantage of this technique comes 
from the Ca and P elements being deposited on the  
substrate, since both bioactive materials are known to  
induce osteoinduction and promote new bone tissue 
growth[201]. 
Micro-arc oxidation (MAO) is an electrochemical process 
which uses a high anodic voltage and high current density to 
create an intense micro-arc (plas ma) near the metal surface 
to induce oxidation. The oxide layer formed  during this 
process is substantially thicker than conventional 
anodization, since the sub-surface of the metal substrate is 
also oxidized[202]. This technique can be used to deposit 
ceramic coatings on valve metals such as Al, Mg, Ta, Ti, W, 
Zn and Zr and their alloys. And by selecting the appropriate 
process parameters, the (MAO) technique can produce high 
quality coatings with superior adhesion, corrosion resistance, 
micro -hardness, wear resistance and strength. In a corrosion 
and wear study by Zhang et al., die cast Mg alloy (AZ91D) 
substrates were treated with a MAO coating. Then both 
treated and untreated substrates were immersed in the Hanks’ 
solution to determine the effectiveness of the MAO coating 
in reducing the corrosion rate[203]. Immersion testing 
revealed that the untreated substrates loss 15 times more 
mass due to corrosion than the MAO treated substrates. In 
addition, the mass loss from the untreated substrates during 
wear tests was 1.5 times greater than those of the MAO 
treated substrates. The tests clearly indicated that the MAO 
surface treatment was effect ive in  improving both the 
corrosion and wear resistance of the Mg alloy. Unfortunately, 
there is no current data available describing the combined 
effects of corrosive and wear on MAO treated Mg alloys in 
Hanks solution. 
In a recent study examin ing the combined effects of 
corrosion and wear on an Mg Alloy (AZ91), Chen et al., 
investigated untreated and MAO treated substrates immersed 
in different composition based solutions composed of NaCl 
and NaHCO3[204]. The study revealed that the MAO coating 
did improve the corrosion resistance of the Mg alloy. 
However, the wear resistance of the treated substrate tended 
to decrease with t ime. The decreasing wear resistance was 
caused by wear debris, which consisted of abrasive particles 
produced by the breakdown of the MAO coating. Both 
anodization and MAO oxide coating can effect ively reduce 
the corrosion rate of Mg and Mg alloys by producing a strong 
resilient oxide layer that provides an effective protective 
barrier between the metal substrate and the fluid 
environment. For example, Song et al. has demonstrated that 
the oxide layer produced during the anodizat ion of a pure Mg 
substrate was capable of providing an  effect ive barrier to 
corrosion for 1 month in Hanks’ solution. During this time 
no hydrogen evolution was detected, indicating that the 
degradation had been delayed[205, 206]. This is an 
important factor for a biodegradable implant, since 
controlling the dissolution rate allows matching of the 
degradation rate of the implant with the growth o f new 
replacement bone tissue. 
4.4. Polymer Coatings 
Many implantable biomedical devices and implants are 
coated with a thin adherent polymeric material that 
effectively isolates the device from the flu idic environment 
of the body. Polymer coatings are frequently used to modify 
the surface properties of biomedical implants to improve 
their biocompatibility, performance and therapeutic 
effectiveness. The interface between implant surface and 
body environment is critical in soliciting the appropriate 
immunological response. Therefore, selecting the correct 
polymer coating is crucial in determin ing the 
biocompatibility of the implant and also provides a wider 
range of design options that can be used to improve the 
surface properties of the original implant surface. For 
example, selecting a polymer coating which slowly 
biodegrades can potentially delay the corrosion of an Mg 
implant and maintain its mechanical integrity over a longer 
timeframe. 
Biomedical coatings can be divided into two primary  
categories: 1) short term, which include d isposable or single 
patient use; and 2) long term applicat ion of prosthetic 
implants and reusable laboratory equipment[207]. To 
achieve the bio-functional requirements and protection, a 
successful polymer coating must adhere to the Mg implant 
and be strong and flexib le enough to withstand the normal 
movement of the implant. The coating should also be capable 
of being sterilised and be sufficiently durable to perform its 
protective function under the expected conditions of the 
particular application[208]. The advantage of polymer 
coatings is that they can be chemically, physically and 
mechanical customized to suit a specific application. Thus, 
being able to select and fine-tune the various properties has 
enabled polymeric materials to be used in  a wide range of 
coating applications such as protection, improved lubricity, 
antimicrobial, adhesion resistance, ultrasonic imaging and 
blood compatible coatings for drug delivery[209]. 
Before coating, an appropriate pre-treatment process is 
required to effectively clean the surface of the Mg implant. 
This process should produce a clean, dry and contaminant 
free surface capable o f provid ing the maximum possible 
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adhesive strength between the polymer and implant surface. 
The presence of entrapped air and moisture on the surface 
could lead to degassing and the format ion of holes in the 
coating during the curing process. The coating process and 
associated coating parameters can influence the resulting 
microstructure and morphology of the polymer coating. This 
explains why coatings with similar compositions can have 
different surface properties[210]. A polymer coating can be 
applied to an Mg implant using a solvent, an aqueous 
solution or from the vapour phase. Water based coating 
techniques have the advantages of eliminating or reducing 
solvent effects on the substrate and are more environmental 
friendly, since there are no toxic solvent wastes produced. 
Polymer coating produced by vapour-deposition can produce 
both uniform and defect-free coatings. The quality and 
chemical structure of these coatings combine to provide an 
effective barrier to the body environment and also enhance 
the protective properties of the coating. For example, 
Parylene (poly (p-xy lylene), is a polymer coating that has 
been used to protect implanted sensors and other biomedical 
devices[210]. 
In addition, Mg needs a suitable surface primer or b inding 
agent to improve the adhesion between the polymer coating 
and the implant surface. Unfortunately, primers composed of 
metallic ions, components of binding agents and almost all 
organic solvents found in paints and similar surface 
preparations are toxic or detrimental to the human body and 
therefore cannot be used in biomedical applicat ions. 
Recently, Huang et al. primed a pure Mg substrate using a 
silane coupling agent before using dip coating technology to 
coat the substrate with degradable poly (lactic acid)[211]. 
The silane coupling agent was found to improve the adhesion 
between the poly (lactic acid) and the substrate. Similarly, 
PLGA, a polymer with good blood compatibility was also 
coated onto a pure Mg substrate using the same process. 
Subsequent corrosion testing in Hanks solution revealed that 
the PLGA could provide an effective coating and protect the 
underlining Mg substrate. However, corrosion protection of 
the Mg substrate was dependent the degradation of the 
PLGA. And in a bone replacement application, the coating 
was unable to provide an adequate protective barrier[211]. In 
a similar study, Xu et  al. was able to show that producing 
different surface modifications on chitosan coatings applied 
to Mg alloy substrates were able to influence the 
biodegradability of the coating[212]. 
Polymeric coatings have the potential to modify the 
surface properties of an Mg based implant and significantly 
improve the implants usability, durability and performance. 
Polymeric materials used in coating an implant have the 
potential to be specifically designed to provide physical, 
chemical and mechanical responses that can be fine-tuned to 
solicit and enhance specific biochemical responses within 
the body environment. However, a significant research effort 
is still needed to find polymeric materials that can produce 
thin, dependable, mult i-functional coatings with controllable 
degradation rates that can be used to prolong the mechanical 
effectiveness of Mg based implants. 
5. Conclusions 
Mg and Mg based alloys are ext remely biocompatib le and 
have similar mechanical properties to natural bone. This 
makes them an  attractive material for the manufacture of 
biodegradable, with the capability to replace many currently 
used orthopaedic materials such as biodegradable 
biopolymers. And despite having the potential to function as 
an osteoconductive and biodegradable substitute in load 
bearing applicat ions, the practical application of Mg based 
alloys faces the serious challenge of overcoming the rapid 
corrosion rates that occur within the physiological 
environment of the body. The types of biological corrosion 
occurring within  the body environment and the influence of 
body fluid pH, concentration of ions, protein adsorption on 
the implant surface and the influence of the surrounding 
tissues was discussed. To overcome the effects of b iological 
corrosion, a number of treatment methods designed to reduce 
the corrosion rate, such as the addition of alloying elements 
and surface modification techniques were discussed. The 
biological consequences of adding alloying elements to 
reduce the corrosion rate was explored and the need for 
careful selection was d iscussed. For example, alloying 
elements such as Al and Li can be used to improve the 
corrosion resistance of an alloy, but the release of their ions 
in the body can create undesirable health problems. 
Therefore, careful selection of the appropriate alloying 
elements and the resulting corrosion by-products were 
discussed in this article. Both these issues are critical for any 
material being considered for a b iomedical application 
within the human body.  
Furthermore, the development of new b ioactive surface 
modifications and coatings, with superior physiochemical 
and mechanical properties has the potential to enhance the 
performance of Mg alloy implants by improving both their 
corrosion and wear resistance. The first type of surface 
modification discussed used conventional mechanical 
processes such as machining and rolling to enhance both 
surface and sub-surface properties. The second type of 
surface modification discussed examined the types of 
physical and chemical surface treatments that could deposit a 
metallic  or ceramic coating  or produce a surface conversion 
coating. The corrosion resistance and biocompatibility of the 
various surface modifications were discussed. In the case of 
ion implantation, the technique gave mixed corrosion 
resistance values when Zn was used to treat an Mg-Ca alloy. 
While a conversion coating technique using a calcium 
phosphate compound produced a coating that not only 
reduced the corrosion rate, but also improved the 
biocompatibility and promoted bone format ion at the surface 
of the Mg alloy. Whilst the use of polymeric coatings to 
protect implanted sensors and biomedical devices is well 
established, further studies are needed to examine the 
viability of using a polymeric material with suitable 
biodegradable properties to extend the operational life  of a 
Mg alloy implant.  
The combination of new Mg alloys and evolving surface 
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modification processes, has presented the opportunity to 
design and develop a biocompatib le material that has the 
potential to be used in an orthopaedic implant. The ability to 
select alloying elements and surface modifications provides 
the opportunity to design a specific Mg alloy implant with 
mechanical properties and biodegradation profile that can be 
tailored to the specific orthopaedic application. However, 
more biomedical studies are needed to investigate the 
interaction between the material surface and the surrounding 
tissue environment.  Also, more in situ experimental studies 
are needed to examine the long-term effects of alloying 
elements released during the bio logical corrosion of Mg 
based alloys. The biomedical, materials science and 
engineering research presented in this review article has 
clearly demonstrated the potential o f using Mg based alloys 
to manufacture orthopaedic implants, but there are still 
challenges to be overcome. The first challenge is to improve 
the corrosion resistance of Mg base alloys by using only 
biocompatible alloying elements and an appropriate 
biocompatible surface treatment that permits the controlled 
degradation of the implant. While the biomedical challenge 
consists of more clinical trials to establish the long-term 
biocompatibility of Mg based alloys and their corrosion 
products within the body environment. 
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